Developed with the European, Middle Eastern and African markets in mind. The product is ideal for burgers, and kebabs.
This new development with ovine cell lines means the company can now produce cultivated lamb at scale and accelerate its innovation focus to expanding into even more animal species.
Passing this milestone
Nicole Johnson-Hoffman, chief executive of Future Meat, said: “In passing this milestone, Future Meat reinforces its position as a leader and pioneer in the cultivated meat industry and shows again the limitless potential of how innovation can drive sustainable solutions.
“The key learnings will be leveraged as we work to produce other meats, including beef and pork, increasing Future Meat's market offerings for consumers.”
Moving forward, as the company prepares to enter the U.S. market, Future Meat will shift its focus to scaling up production of its cultivated meat products – including lamb and chicken – at its new production facility, which is expected to break ground in 2022.
Michael Lenahan, general manager of Future Meat, added: “Since lamb has a uniquely distinct flavor, it is very clear if a cultivated substitute is on or off the mark.
“The reason Future Meat's cultivated lamb is indistinguishable from conventional lamb is because it is, first and foremost, real meat. It sizzles, sears and tastes just like people expect—it's amazing."
Israeli start-up Future Meat has achieved some of the most cost-effective work on scale to date, as Sagentia Innovation highlights in its whitepaper From barn to bioreactor .
Future Meat has backing from Archer Daniels Midland, Tyson Foods and S2G. "The company is now producing 110g of chicken breast for just under $4, down from $7.50 at the start of 2021," the whitepaper states. "However, it is worth noting that this compares to an average price of just $0.80 for a traditional chicken breast in the US."